The largest database of trusted experimental protocols

Quantitech reverse transcription kit

Manufactured by Qiagen
Sourced in Germany, United States, United Kingdom

The QuantiTech Reverse Transcription Kit is a laboratory product designed for the conversion of RNA into cDNA. It facilitates the reverse transcription process, which is a crucial step in gene expression analysis and other molecular biology applications.

Automatically generated - may contain errors

112 protocols using quantitech reverse transcription kit

1

Quantitative PCR Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from cells using the RNeasy isolation kit (Qiagen), and cDNA prepared using the Quantitech Reverse Transcription kit (Qiagen). SYBR-green-based quantitative PCR assays were deigned and optimized for HLA-C and Hprt. Samples collected from tissue such as dissected implantation sites from pregnant mice or organs were cut into small pieces and immersed in RNAlater (Qiagen) as per manufacturer’s instructions, prior to processing for RNA isolation. The sequences of the primers used for the assays are provided in Supplementary Data 10. Standard curves for each of the assays were performed using serial dilutions of cDNA and amplification efficiencies were determined. Relative expression was expressed as 2–ΔCt, where ΔCt is the difference of the cycle threshold between the transcript of the gene of interest and the reference gene transcript.
+ Open protocol
+ Expand
2

Quantitative RT-PCR for gene expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-qPCR was performed to detect mRNA expression levels of target genes in samples as previously described [12 (link)]. Trizol reagent (Invitrogen) was used to extract total RNA and complementary DNA (cDNA) was prepared using the QuantiTech Reverse Transcription kit (Qiagen). The RT-PCR was performed on Rotor Gene 3000 by using QuantiTect SYBR Green PCR kit, according to the instructions. β-Actin was used as reference gene, and results were expressed as the relative expression ratio of target gene to reference gene. The sequences and amplicon size for the primers are listed in Table 1.
+ Open protocol
+ Expand
3

Quantitative RT-PCR Analysis of Hematopoietic Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA isolation was performed using the RNeasy Mini kit (Qiagen) with additional DNase (Qiagen) step using manufacturer’s protocol. cDNAs were prepared using Quantitech reverse transcription kit (Qiagen), and quantitative polymerase chain reaction (qPCR) for GAPDH, glycophorin A (GYPA), haemoglobin subunit epsilon (HBE), haemoglobin subunit gamma (HBG), and beta globin (HBB) was performed with the Lightcycler 480 SYBR Green I Master Mix (Roche) on the Lightcycler 480 (Roche); qPCR for GAPDH and HOXA7 with the SYBR Select Master Mix (Life Technology, LT) using the ViiA™ 7 Real-Time PCR System (LT); and qPCR for GAPDH, HOXA3, HOXA5, HOXA6, and HOXA9 was performed with the TaqMan%reg; Gene Expression Master Mix (LT) and analyzed using the ViiA™ 7 Real-Time PCR System (LT). SYBR Green-compatible primers were obtained from the PrimerBank database or literature58 (link), 59 (link). Taqman%reg; primers were purchased from LT. Primers were tested against OP9-M2 cDNA to rule out amplification of murine genes, and gDNA or water as negative controls. Primers are presented in Supplementary Table 6.
+ Open protocol
+ Expand
4

qRT-PCR Analysis of VGF Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using RNAqueous kit (Ambion, CA, USA). 1 μg of total RNA was reverse‐transcribed using Quantitech reverse transcription kit (Qiagen, West Sussex, UK). qRT–PCR was performed using SYBR green method on an ABI7500 cycler (Applied Biosystems, CA, USA). All primers were obtained from PrimerDesign (Southampton, UK). The VGF primer sequences were as follows: forward 5′‐TGAGACTTTGACACCCTTATCC and reverse 5′‐GGAACCGCCCAGGAATGA. Run conditions were as follows: 50 °C for 2 min, 95 °C for 15 min followed by 40 cycles of 95 °C for 15 sec, 60 °C for 30 sec, and 72 °C for 1 min. Data are presented as fold change relative to control after normalization to the mean of housekeeping genes B2M and RPL13 (PrimerDesign proprietary primer sequences).
+ Open protocol
+ Expand
5

DMS Production by SAR116 Strain IMCC1322

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine whether a strain belonging to the SAR116 group can produce DMS from DMSP, the IMCC1322 strain, which is one of two isolates belonging to SAR116 [35 (link)], was grown in the R2A broth. When the strain grew to an OD620 of 0.03, the culture was dispensed in two 30-ml sterile vials. Then, the DMSP substrate (final conc. of 500 μM) was injected into one of the vials, and DMS concentrations in the medium were quantified using DMS extraction, a trapping device, and a gas chromatograph equipped with a flame photometric detector (GF-FPD; [36 ]). Following the addition of DMSP, 50–100 μl of the samples was removed using a 250-μl gastight syringe (Hamilton 1725RN; Sigma-Aldrich, St. Louis, MO, USA). Sequential DMS measurements were carried out over periods of 15 min to 8 h. Abiotic control, containing the same concentration of DMSP substrate and filtered seawater, was prepared in parallel to correct for any background sources of DMS [37 ].
Reverse transcription (RT)-PCR was performed to examine expression of the dddP gene in IMCC1322 in the absence and presence of the DMSP substrate. Total RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. cDNA was prepared from the RNA using the QuantiTech Reverse Transcription Kit (Qiagen). Subsequent PCR was conducted using the primer sets targeting 16S rRNA and dddP genes (S1 Table).
+ Open protocol
+ Expand
6

Quantitative Analysis of CCND1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted and purified using RNeasy Mini Kit (Qiagen, Hilden, Germany) following the manufacturer′s instruction. Reverse-transcription reaction was performed using QuantiTech Reverse Transcription Kit (Qiagen) to prepare cDNA samples. The quantitative real-time PCR (qRT-PCR) was conducted by QuantiTect SYBR Green PCR Kit (Qiagen) with 1 µM primers for CCND1 (right: 5′-GACCTCCTCCTCGCACTTCT-3′; left: 5′-GAAGATCGTCGCCACCTG-3′; Invitrogen, USA) on LightCycler 480 real-time PCR system (Roche, Basel, Switzerland). The expression of GAPDH was used as endogenous control (right: 5′-GCCCAATACGACCAAATCC-3′; left: 5′-GCTAGGGACGGCCTGAAG-3′ Invitrogen, USA) for the normalization of gene expression of CCND1.
+ Open protocol
+ Expand
7

Fear Conditioning mPFC RNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
mPFC derived from fear-conditioned mice was homogenized in nuclear buffer (detailed in Supplement 1) followed by RNA extraction using the RNAeasy Mini kit (Qiagen, Hilden, Germany). Reverse transcription and cDNA synthesis was performed following the Quantitech Reverse Transcription kit protocol (Qiagen, Hilden, Germany), with the exception of RNA eluted from RNA immunoprecipitation (RIP) assays, which was reverse transcribed using Super Script III First Strand Synthesis (Invitrogen, Carslbad, CA, USA). The assay was validated both in vitro and in vivo (Fig S6 A-B in Supplement 1).
+ Open protocol
+ Expand
8

Quantifying CCL20 Expression in Antigen-Positive LECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five mice per group were immunized with 60 μg ova488, 30 μg αCD40, and 30 μg poly(I:C). About 12–14 days later, mice were killed and draining LNs were digested as described above. Cells were stained with CD45-PE. Cells then underwent negative selection using anti-PE microbeads and LS columns from Milltenyi and sorted on a BD FACsAria II cell sorter (BD Biosciences, San Jose, CA) based on the lack of CD45, PDPN+, CD31+, and fluorescent antigen (Supplementary Fig. 1, bottom). Antigen-positive and antigen-negative cells were run through a QIAshredder (catalog number 79656, Qiagen, Hilden, Germany) before RNA was isolated using an RNA micro kit (catalog number 74004, Qiagen, Hilden, Germany). Complimentary DNA (cDNA) was made using the Qiagen Quantitech Reverse Transcription kit (catalog number 205314, Qiagen, Hilden, Germany). Taqman Primers to CCL20 (Assay ID number Mm01268754_m1) and the control gene, GusB (Assay ID number Mm01197698_m1), were purchased from Thermo Fisher (Waltham, MA) and run on a Thermo Fisher Step 1 plus real-time PCR machine. cDNA was quantified using the delta-delta CT method to establish the fold increase in CCL20 from antigen + LECs compared to antigen-LECs. Experiments were completed three times and five mice per group were pooled for qRT-PCR. An unpaired t-test was used to determine statistical significance.
+ Open protocol
+ Expand
9

Quantitative RNA-to-cDNA Conversion

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was prepared using Trizol (Life Technologies) and cDNA prepared using Quantitech Reverse Transcription Kit (QIAGEN), both as per manufacturer’s instructions, using 5, 10, and 20 ng RNA templates to ensure the reaction was quantitative. qPCR was conducted using SyBr green (Quanta) and the Bio-Rad CFX platform, with a 60°C annealing temperature and the primer pairs that are tabulated in the Supplemental Experimental Procedures.
+ Open protocol
+ Expand
10

Whole Embryo Total RNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from whole embryos as described by Lee-Liu et al. (2012) (link). cDNA was synthesized using the QuantiTech Reverse Transcription Kit (Qiagen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!